Peter Heerma, CHIEF COMMERCIAL OFFICER at Travere Therapeutics, Inc. (TVTX), sold 2,662 shares at $30.00 ($80K) on 2025-10-28, disclosed to the SEC on 2025-10-30.
Scheduled sale ($80k) by CHIEF COMMERCIAL OFFICER under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| Filing → |
| TVTX | SELL | 2026-04-15 | $303K | — | Filing → |
| TVTX | SELL | 2026-02-03 | $235K | — | Filing → |
| TVTX | SELL | 2025-12-29 | $199K | — | Filing → |